This is a double-blind, placebo-controlled, multi-center, dose-escalation study to assess the
safety, tolerability, Pharmacokinetics and Pharmacodynamics of single and multiple ascending
intravenous infusions of CytoFab (AZD9773) in adult patients with severe sepsis.